Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells

Cancer Research

Volumn 61, Issue 17, 2001, Pages 6511-6516

  Wickström, Sara A ^a   Veikkola, Tanja ^a   Rehn, Marko ^b   Pihlajaniemi, Taina ^b   Alitalo, Kari ^a   Keski Oja, Jorma ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COLLAGEN TYPE 18; ENDOSTATIN; PAXILLIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; UNCLASSIFIED DRUG; UROKINASE; VINCULIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL ADHESION; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; CYTOSKELETON; DISSOCIATION; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; STRESS;

ACTINS; ANGIOGENESIS INHIBITORS; APOPTOSIS; CELL ADHESION; CELL MEMBRANE; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; COLLAGEN TYPE XVIII; CYTOSKELETON; ENDOSTATINS; ENDOTHELIUM, VASCULAR; FOCAL ADHESIONS; HUMANS; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SOLUBILITY; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035419429     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Regulators of angiogenesis
3. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
4. Mechanisms of angiogenesis
5. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
6. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
7. Cloning, expression, and in vitro activity of human endostatin
8. Endostatin induces endothelial cell apoptosis
9. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
10. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
11. The molecular architecture of focal adhesions
12. Cancer invasion and tissue remodeling-cooperation of protease systems and cell types
13. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β
14. Growth factors in the regulation of pericellular proteolysis: A review
15. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition
16. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway
17. The plasminogen-plasmin system in malignancy
18. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways
19. The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface
20. Inhibition of receptorbound urokinase by plasminogen-activator inhibitors
21. Identification of the urokinase receptor as an adhesion receptor for vitronectin
22. Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human epithelial cells
23. The urokinase receptor is a major vitronectin-binding protein on endothelial cells
24. The serpin PAI-1 inhibits cell migration by blocking integrin α V β 3 binding to vitronectin
25. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices
26. 2-terminal domain of the urokinase receptor
27. Interaction of endostatin with integrins implicated in angiogenesis
28. A study of proteases and protease-inhibitor complexes in biological fluids
29. Autocrine saturation of pro-urokinase receptors on human A431 cells
30. Nonenzymatic interactions between proteinases and the cell surface: Novel roles in normal and malignant cell physiology
31. Cooperative effect of TNFα, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity
32. A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method
33. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading
34. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release
35. Requirement of receptor-bound urokinase-type plasminogen activator for integrin avβ5-directed cell migration
36. Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions
37. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation
38. Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth
39. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain
40. Syndecans: Synergistic activators of cell adhesion
41. Structural basis and potential role of heparin/heparin sulfate binding to the angiogenesis inhibitor endostatin